(Q40569139)

21 September 2017

Identification of genes that are regulated transcriptionally by Myc in childhood tumors (English)

1 reference

21 September 2017

Elizabeth A Raetz

1

1 reference

21 September 2017

Marianne K H Kim

2

1 reference

21 September 2017

Philip Moos

3

1 reference

21 September 2017

Marlee Carlson

4

1 reference

21 September 2017

Carol Bruggers

5

1 reference

21 September 2017

David K Hooper

6

1 reference

21 September 2017

Laura Foot

7

1 reference

21 September 2017

Tong Liu

8

1 reference

21 September 2017

Robert Seeger

9

1 reference

21 September 2017

William L Carroll

10

1 reference

21 September 2017

language of work or name

English

0 references

publication date

1 August 2003

1 reference

21 September 2017

1 reference

21 September 2017

98

1 reference

21 September 2017

841-853

1 reference

21 September 2017

4

1 reference

c-Myc target genes involved in cell growth, apoptosis, and metabolism

21 September 2017

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11584

Involvement of Myc targets in c-myc and N-myc induced human tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11584

7 January 2021

Myc oncogenes: the enigmatic family

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11584

7 January 2021

https://api.crossref.org/works/10.1002%2FCNCR.11584

1 reference

7 January 2021

c-Myc represses transcription in vivo by a novel mechanism dependent on the initiator element and Myc box II

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11584

7 January 2021

A link between c-Myc-mediated transcriptional repression and neoplastic transformation

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11584

7 January 2021

Myc-mediated transformation: the repression connection

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11584

7 January 2021

Amplification of N-myc in untreated human neuroblastomas correlates with advanced disease stage

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11584

7 January 2021

Association of multiple copies of the N-myc oncogene with rapid progression of neuroblastomas

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11584

7 January 2021

Altered growth and phenotype in clonal mycN transfectants of the SK-N-SH neuroblastoma cell line

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11584

7 January 2021

Human N-myc gene contributes to neoplastic transformation of mammalian cells in culture.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11584

7 January 2021

MYCN expression is not prognostic of adverse outcome in advanced-stage neuroblastoma with nonamplified MYCN

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11584

7 January 2021

New Myc-interacting proteins: a second Myc network emerges

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11584

7 January 2021

The Myc/Max/Mad network and the transcriptional control of cell behavior

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11584

7 January 2021

Expression of the c-Myc protein in childhood medulloblastoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11584

7 January 2021

Diversity of the apoptotic response to chemotherapy in childhood leukemia

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11584

7 January 2021

Gene-Expression Profiles in Hereditary Breast Cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11584

7 January 2021

Quantification of MYCN, DDX1, and NAG gene copy number in neuroblastoma using a real-time quantitative PCR assay.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11584

7 January 2021

Successful treatment of stage III neuroblastoma based on prospective biologic staging: a Children's Cancer Group study

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11584

7 January 2021

Comprehensive analysis of chromosome 1p deletions in neuroblastoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11584

7 January 2021

Prognostic significance of age, MYCN oncogene amplification, tumor cell ploidy, and histology in 110 infants with stage D(S) neuroblastoma: the pediatric oncology group experience--a pediatric oncology group study.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11584

7 January 2021

Biologic factors determine prognosis in infants with stage IV neuroblastoma: A prospective Children's Cancer Group study

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11584

7 January 2021

Telomerase activity by TRAP assay and telomerase RNA (hTR) expression are predictive of outcome in neuroblastoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11584

7 January 2021

Biologic variables in the outcome of stages I and II neuroblastoma treated with surgery as primary therapy: a children's cancer group study

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11584

7 January 2021

Treatment of high-risk neuroblastoma with intensive chemotherapy, radiotherapy, autologous bone marrow transplantation, and 13-cis-retinoic acid. Children's Cancer Group

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11584

7 January 2021

Molecular biology of neuroblastoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11584

7 January 2021

N-Myc gene amplification is a major prognostic factor in localized neuroblastoma: results of the French NBL 90 study. Neuroblastoma Study Group of the Société Francaise d'Oncologie Pédiatrique

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11584

7 January 2021

Clinical relevance of tumor cell ploidy and N-myc gene amplification in childhood neuroblastoma: a Pediatric Oncology Group study

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11584

7 January 2021

Prognostic significance of MYCN oncogene expression in childhood neuroblastoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11584

7 January 2021

N-myc enhances the expression of a large set of genes functioning in ribosome biogenesis and protein synthesis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11584

7 January 2021

Expression analysis with oligonucleotide microarrays reveals that MYC regulates genes involved in growth, cell cycle, signaling, and adhesion

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11584

7 January 2021

The transcriptional program of a human B cell line in response to Myc

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11584

7 January 2021

Gene-target recognition among members of the myc superfamily and implications for oncogenesis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11584

7 January 2021

A DNA microarray screen for genes involved in c-MYC and N-MYC oncogenesis in human tumors.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11584

7 January 2021

Myc family oncoproteins function through a common pathway to transform normal cells in culture: cross-interference by Max and trans-acting dominant mutants

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11584

7 January 2021

Id2 is a retinoblastoma protein target and mediates signalling by Myc oncoproteins

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11584

7 January 2021

ID2 expression in neuroblastoma does not correlate to MYCN levels and lacks prognostic value.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11584

7 January 2021

Direct activation of RNA polymerase III transcription by c-Myc

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11584

7 January 2021

The role of c-myc in cellular growth control

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11584

7 January 2021

The receptor for ciliary neurotrophic factor

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11584

7 January 2021

In vivo localization and characterization of functional ciliary neurotrophic factor receptors which utilize JAK-STAT signaling

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11584

7 January 2021

The ciliary neurotrophic factor and its receptor, CNTFR alpha

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11584

7 January 2021

Signaling pathway of ciliary neurotrophic factor in neuroblastoma cell lines

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11584

7 January 2021

The oncoprotein 18/stathmin family of microtubule destabilizers

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11584

7 January 2021

Development of ribozymes that target stathmin, a major regulator of the mitotic spindle

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11584

7 January 2021

Histone deacetylases, transcriptional control, and cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11584

7 January 2021

Complex roles of tissue inhibitors of metalloproteinases in cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11584

7 January 2021

Tissue inhibitors of metalloproteinases and programmed cell death: conundrums, controversies and potential implications.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11584

7 January 2021

Inhibition of invasion and induction of apoptotic cell death of cancer cell lines by overexpression of TIMP-3.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11584

7 January 2021

Tissue inhibitor of metalloproteinase-3 induces a Fas-associated death domain-dependent type II apoptotic pathway

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11584

7 January 2021

Cancer gene therapy with tissue inhibitors of metalloproteinases (TIMPs).

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11584

7 January 2021

https://api.crossref.org/works/10.1002%2FCNCR.11584

1 reference

7 January 2021

Identifiers

DOI

10.1002/CNCR.11584

1 reference

21 September 2017

1 reference